Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Allison M. Wilkin
Institution:
Ottawa Hospital Research Institute
Observed institution:
Ottawa Hospital Research Institute
ORCID:
0000-0002-6677-5293
Observed ORCID:
0000-0002-6677-5293
OpenAlex ID:
A5106613385
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies
2024
·
Sita Bhella
, Allison M. Wilkin
, et al.
·
Vaccine
·
9
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy
2025
·
C. Arianne Buchan
, Gerard Agbayani
, et al.
·
Transplantation and Cellular Therapy
·
4
COVID-19 Humoral Immunity Improves with Third and Subsequent Vaccine Doses in Patients with Plasma Cell Dyscrasias, Particularly in Those Receiving antiCD38 Therapy
2024
·
Sita D. Bhella
, Allison M. Wilkin
, et al.
·
Blood
·
2
PDF
Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias
2026
·
Sita Bhella
, Gerard Agbayani
, et al.
·
Blood Advances
PDF
Incremental immunogenicity of multiple doses of SARS ‐ CoV ‐2 vaccination in patients with haematological malignancies
2025
·
Abi Vijenthira
, Sita Bhella
, et al.
·
British Journal of Haematology
Show more works
View as search
Works count:
5
Citation count:
15
H-index:
2
I10-index:
Year
Topic
Type